The global allergy diagnostics market, poised to reach USD 11.63 billion by 2030, is expanding at a CAGR of 10.39% from 2025. The rise in allergies highlights the need for precise diagnostics. Major players like Thermo Fisher and Siemens are innovating to meet demand. Key growth regions include North America and Asia Pacific.
The global allergy diagnostics market, poised to reach USD 11.63 billion by 2030, is expanding at a CAGR of 10.39% from 2025. The rise in allergies highlights the need for precise diagnostics. Major players like Thermo Fisher and Siemens are innovating to meet demand. Key growth regions include North America and Asia Pacific.
This new leadership programme empowers senior professionals to apply strengths science for team growth and business success.
SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- Strengths School™,...
SINGAPORE, Aug. 10, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™...
SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™...
SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™...
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide.
FRANKFURT, Germany, Aug. 8, 2025 /PRNewswire/...
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide.
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide.
The fully operational Individual Access Services (IAS) solution under TEFCA will deliver on the promise of truly connected healthcare by giving patients and providers...
DELRAY BEACH, Fla., Aug. 8, 2025 /PRNewswire/ -- 360Quadrants has released its latest Hospital Information System Startups/SMEs, 2025, recognizing key players, including both global...
Burlingame, CA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The global Medical Technology Platform Market is estimated to be valued at USD 31.59 Bn in 2025 and is expected to reach USD 67.26 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032. The medical technology platform market is experiencing rapid growth, driven by the integration of advanced technologies such as artificial intelligence, cloud computing, Internet of Medical Things (IoMT), and big data analytics. These platforms enable seamless healthcare delivery through telemedicine, remote patient monitoring, diagnostics, and personalized treatment solutions. Trends such as interoperability, predictive analytics for disease management, and patient-centric digital ecosystems are reshaping the healthcare landscape. Rising demand for connected, data-driven care, coupled with regulatory support and the push for value-based healthcare, is positioning the medical technology platform market as a key driver of future medical innovation and efficiency.
- Strategic investment to support RBL's mission to launch and scale breakthrough startups
- Founder and general partner of Modi Ventures, Sahir Ali, to join...